Cero Therapeutics Funding: $40M Raised, Series A (2020)
Cero Therapeutics is based in South San Francisco. It has raised $40M in total funding. Latest round: Series A.
Cero Therapeutics funding overview
Cero Therapeutics is based in South San Francisco. Cero Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2020. The round record for Cero Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner, Milky Way Investments. 5 distinct backers are named across the disclosed rounds.
Cero Therapeutics at a glance
Total raised
$40M
Latest round
Series A
Latest round date
March 2020
Headquarters
South San Francisco
Notable investors
Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner, Milky Way Investments
Frequently asked about Cero Therapeutics funding
How much has Cero Therapeutics raised?
Cero Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Cero Therapeutics?
Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner, Milky Way Investments are named among the investors backing Cero Therapeutics.
What was the latest Cero Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2020.
Where is Cero Therapeutics based?
Cero Therapeutics is based in South San Francisco.
When did Cero Therapeutics last raise?
The last disclosed Cero Therapeutics round closed in March 2020 at Series A.
Round data for Cero Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in South San Francisco and backer lists below.
